Darmstadt, Germany (ots/PRNewswire) - - Global collaboration to extend the portfolio of Merck Serono, a leading company in fertility treatment, in the growing market of fertility technologies to support standardization and improve fertility outcomes - Merck receives global marketing and commercialization rights for ...
London (ots/PRNewswire) - ViiV Healthcare, Aurobindo Pharma, and the Clinton Health Access Initiative, Inc. (CHAI) announced today that Aurobindo Pharma has submitted an Abbreviated New Drug Application (ANDA) for dolutegravir 50mg, for Tentative Approval, to the Food and Drug Administration (FDA), for the treatment ...
Darmstadt, Germany (ots/PRNewswire) - - Hypothyroidism is a disease affecting millions which often goes unrecognized - Symptoms of hypothyroidism often mistaken for other diseases Merck Serono, the biopharmaceutical business of Merck, today announced the support of 7th International Thyroid Awareness Week (ITAW). This year's campaign launched today for ITAW is aimed at ...
Darmstadt, Germany (ots/PRNewswire) - Not intended for UK based media CHMP recommendation based on results from the Phase IIIb SPARK study Merck Serono, the biopharmaceutical business of Merck, today announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued ...
Darmstadt, Germany (ots/PRNewswire) - - NOT INTENDED FOR US AND UK BASED MEDIA - ASCO Abstract # Avelumab*: 3023, 3044, 3055, TPS9086, TPS3101, 4042, 4047, 5509, 8034; evofosfamide: TPS9089, 8579; tepotinib: 2591; tecemotide[*]: 3036. - New data on priority candidates from Merck's oncology and immuno-oncology ...
London (ots/PRNewswire) - Bryan, Garnier & Co, the pan-European investment bank for growth companies, announces the successful $275 million Nasdaq IPO for Galapagos NV, a major European clinical-stage biotechnology company. Bryan, Garnier & Co is the only European investment bank in the IPO syndicate. The Galapagos ...
Darmstadt, Germany (ots/PRNewswire) - - NOT INTENDED FOR US AND UK BASED MEDIA - - Evofosfamide is an investigational compound currently in Phase III trials - Advanced pancreatic cancer is second indication to receive FDA fast track designation for evofosfamide Merck, a leading company for innovative and top-quality ...
Sumitomo Dainippon Pharma Co Ltd and Takeda Pharmaceutical Company Limited
Osaka, Japan (ots/PRNewswire) - Sumitomo Dainippon Pharma Co., Ltd. ("Sumitomo Dainippon Pharma") (Head Office: Osaka, Japan: President: Masayo Tada) and Takeda Pharmaceutical Company Limited ("Takeda") (Head Office: Osaka, Japan: President and CEO: Christophe Weber) today jointly announced that their license ...
London (ots/PRNewswire) - First programme to evaluate dual HIV maintenance therapy with dolutegravir and rilpivirine ViiV Healthcare today announced the start of a Phase III clinical trial programme to evaluate the safety and efficacy of dolutegravir (Tivicay(R)) and rilpivirine (Edurant(R)[1]) as maintenance ...
Venlo, The Netherlands (ots/PRNewswire) - QIAGEN N.V. has posted its 2014 Annual Report on its website at http://www.qiagen.com/About-Us/Investors/Financial-Information/Financial-Reports QIAGEN's Annual Report on Form 20-F for the year ended December 31, 2014 has been filed with the U.S. Securities and Exchange Commission (SEC) on February 27, 2015, a copy of which can be found on the website of the SEC at ...
Paris (ots/PRNewswire) - A revolution in HIV testing The French company AAZ has announced that it has received the CE mark for the first self-administered HIV blood test which will be manufactured in France under the name autotest VIH(R). (Photo: http://photos.prnewswire.com/prnh/20150430/742768-a ) (Photo: http://photos.prnewswire.com/prnh/20150430/742768-b ) autotest VIH(R) will be available in pharmacies and on ...
Calgary, Alberta (ots/PRNewswire) - The deal structure involves CAD$50 million in equity investments, and future China sales milestones and licensing royalties that could represent in excess of US$400 million Resverlogix Corp. ("Resverlogix" or the "Company") today announced that it has entered into a Framework ...
Tokyo (ots/PRNewswire) - - The European Committee for Medicinal Products for Human Use recommended approval of once-daily Lixiana(R) - The positive opinion is based on data from the ENGAGE AF-TIMI 48 and Hokusai-VTE studies, the largest single comparative global trials of a novel oral anticoagulant in patients with ...
European Liver Patients Association (ELPA)
Brussels (ots/PRNewswire) - There are approximately nine million people in Europe infected with the hepatitis C virus, with tens of thousands of new cases diagnosed each year - and this trend is rising.[1] Currently there is no single online resource where people diagnosed with hepatitis C can go to find out more ...
Munich (ots) - Introduction of new "Elements" completes the portfolio of automated, indication-specific planning tools for radiosurgery/SBRT The "Elements" strategy-indication-specific focused software applications aimed at enhancing the workflow for difficult to treat indications in the brain and spine introduced in 2013-comes full circle with the introduction of ...
Lausanne, Switzerland (ots/PRNewswire) - One year after the initiation of Phase I, Debiopharm announced the start of clinical phase II for Debio 1450 in ABSSSI and presentation of new data at ECCMID Debiopharm International SA (Debiopharm), part of Debiopharm Group(TM), a Swiss-based global biopharmaceutical ...
Darmstadt, Germany And New York (ots/PRNewswire) - Not intended for UK-based media - First of several registration trials expected to start in 2015 for the alliance between Merck and Pfizer - Initiation and first patient treated in Phase III clinical study recruiting across approximately 290 sites in more than 30 ...
Lyon, France (ots/PRNewswire) - European vaccine leader hosts events across the region to help raise awareness of immunization throughout life Sanofi Pasteur MSD welcomes the World Health Organization's European Immunization Week 2015 (EIW 2015) with a series of awareness-raising events across the region, taking place between April 20th and 25th. Sanofi Pasteur MSD, a European leader for vaccines in Europe, has joined ...
Geneva (ots/PRNewswire) - ASSESS shows plasma circulating tumour DNA (ctDNA) testing for EGFR mutation is a viable alternative to tumour biopsy IGNITE supports value of EGFR mutation testing in all patients with advanced NSCLC AstraZeneca today presented results from two key studies showing the effectiveness of plasma circulating tumour DNA (ctDNA) testing for ...
Lausanne, Switzerland (ots/PRNewswire) - Debiopharm presents preclinical results for 2 anti-cancer targeted therapies Debio 1143 and Debio 1347 Debiopharm International SA (Debiopharm), part of Debiopharm Group(TM), a Swiss-based global biopharmaceutical company developing prescription drugs that target unmet ...
Tokyo (ots/PRNewswire) - Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced that Swissmedic, the regulatory authority of Switzerland, has granted approval of Lixiana(R) (edoxaban), an oral, once-daily selective factor Xa inhibitor, for the prevention of stroke and systemic embolism (SE) in ...
Bagsværd, Denmark (ots/PRNewswire) - Today, Novo Nordisk announced a three-year extension of its Changing Diabetes(R) in Children programme. Since 2009, free insulin and access to diabetes care have been provided to more than 13,000 children in nine countries in Africa and South-East Asia. During the five years, 108 diabetes clinics have been established and 5,479 ...
Edmonton, Alberta (ots/PRNewswire) - Stock Market Symbols GIB.A (TSX) GIB (NYSE) http://www.cgi.com/newsroom CGI is pleased to announce the renewal of its application maintenance services (AMS) contract with the Ministry of Health in Alberta (Alberta Health) for three years. The original contract was signed in 2011 for three and a half years, and the high quality work ...
Darmstadt, Germany And New York (ots/PRNewswire) - Not intended for UK-based media - In the second and third quarters of 2015, Merck and Pfizer will begin co-promoting XALKORI in the United States, Canada, Japan and five European Union countries (France, Germany, Italy, Spain and the United Kingdom) - In the United States and Canada, XALKORI will be co-promoted by EMD ...
Calgary, Alberta (ots/PRNewswire) - Resverlogix Corp. ("Resverlogix" or the "Company") announces that it has received two China patent approvals covering RVX-208. A composition of matter patent, China No. 2007 8 0052349.8 titled, "Compounds for the Prevention and Treatment of Cardiovascular Disease" was granted until February 2027. A manufacturing patent, China No. ZL 2009 8 0106586.7 titled, "Methods of Preparing ...
Shire Pharmaceuticals Group Plc
Lexington, Massachusetts (ots/PRNewswire) - - Potential Launch of SHP465 Anticipated in Second Half of 2017 - Exclusivity for Shire's Overall ADHD Product Portfolio Extends to 2029 Shire plc today announces that it has reached an agreement with the U.S. Food and Drug Administration (FDA) on a clear regulatory path ...
Shire Pharmaceuticals Group Plc
Lexington, Massachusetts (ots/PRNewswire) - Shire plc acknowledges the two petitions filed with the U.S. Patent and Trademark Office (USPTO) on April 2nd by Hayman Capital Management regarding LIALDA(R) (mesalamine) and GATTEX(R) (teduglutide [rDNA origin]). The patents listed in the FDA Orange Book for LIALDA and GATTEX protect the innovation and value Shire brings to patients who benefit from these important medicines. ...
Woodbridge, Ontario (ots/PRNewswire) - Pivotal Therapeutics Inc. (OTCQX:PVTTF; CSE:PVO), ("Pivotal" or the "Company"), a specialty pharmaceutical company with a focus on Omega-3 therapies for cardiovascular disease and overall health, announced today that the United Stated Patent and Trademark Office (USPTO) has ...
Takeda Pharmaceuticals Europe Ltd
Vienna (ots/PRNewswire) - FOR MEDICAL MEDIA Takeda Pharmaceuticals International GmbH ("Takeda") and Sunovion Pharmaceuticals Inc. ("Sunovion") today announced the results from three post-hoc analyses evaluating the efficacy and safety of Latuda(R) (lurasidone) in patients with schizophrenia at the 23rd European ...
Lausanne, Switzerland (ots/PRNewswire) - For non-US media - Global Rosacea Tweetathon set to bring the realities of living with rosacea under the spotlight #ChatRosacea Today the world's first Global Rosacea Coalition, supported by the National Rosacea Society and many leading rosacea experts, called for greater ...